Opportunity Alert: The MedTech Place To Be in October

The AdvaMed 2012: The MedTech Conference  is October 1 – 3 in  Boston.  AZBio and te Arizona Commerce Authority will be on hand to spread the word about the great things happening here iin AZ, we donlt want to do it aone.  Help us leverage this investment by coming along and joining us at AdvaMed 2012.

AdvaMed 2012 is the leading MedTech Conference for global CEOs, regulatory, reimbursement/payment, business development executives and investors.  Last year, 34% of the attendees had the title of vice president and above –  of these, 420 were presidents, CEOs, or other C-suite executives.

With more than 800 companies in attendance, AdvaMed 2012 is the most efficient and cost effective business development and capital formation event you will find.

Whatever your goals are for this year:  from new insights on regulatory issues, access to capital, partnering opportunities with innovative technologies and products, or making connections with key industry leaders – you can do it all at AdvaMed 2012.

AdvaMed 2012 Opportunities:

* Connect with hundreds of potential business partners. View the 188 investors, corporate business development, and finance executives who attended in 2011 – this year we expect 250.

* Showcase your company – don’t miss out on the opportunity to make a presentation about your company to a large number of investors, get financing and form valuable partnerships. Apply here before June 4th.

* Gain insights from industry experts on a wide range of highly relevant topics, including intimate CEO Unplugged sessions, which feature the biggest names in the industry.

* Learn best practices from company executives who have recently acquired FDA approval or secured insurance reimbursement.

* Take advantage of the partnering software to schedule private meetings on-site with other attendees.

Register Now to attend all 3 days of AdvaMed 2012 at a price as low as $895 for emerging growth companies.

 

Posted in AZBio News, Opportunities and tagged .